MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-28-0033795
Ingram Biosciences Private Limited - pharma in Noida, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.62 Cr
▲ 115% YoY
Net profit · FY 2024
₹3.27 Lakh
Net margin 1.2%
EBITDA · FY 2024
₹5.82 Lakh
EBITDA margin 2.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Ingram Biosciences Private Limited
Data last updated:
Ingram Biosciences Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24230UP2019PTC116200. Its GSTIN is 07AAFCI2541C1Z1 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jeet Mala and Sakshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1203 2nd Floor Ats Greens – 2 Plot No A – 58 Sector 50, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.62 Cr, a growth of 115% compared to the previous year. For the same year it recorded a net profit of ₹3.27 Lakh (net margin 1.2%) and EBITDA of ₹5.82 Lakh (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 80% over three years.
Ingram Biosciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0033795). For more details, the company can be reached via its website ingrambiosciences.com.
Company details
CIN U24230UP2019PTC116200
Registration Number 116200
Incorporation Date 24 April 2019
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-28-0033795
Key People
Jeet Mala Director Sakshi Director Recognitions & Rankings of Ingram Biosciences
Contact details
Ingram Biosciences Private Limited's registered office is in Noida, Uttar Pradesh. Its website is ingrambiosciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1203 2nd Floor Ats Greens – 2 Plot No A – 58 Sector 50, Noida, Uttar Pradesh, India – 201301
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ingram Biosciences Private Limited, buy the company report.
Comprehensive company report
Ingram Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ingram Biosciences is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Ingram Biosciences Private Limited, buy the company report.
Financials of Ingram Biosciences Private Limited
FY 2025 filings availableIngram Biosciences Private Limited reported revenue of ₹2.62 Cr (up 115% YoY) for FY 2024.
Revenue · FY 2024
₹2.62 Cr ▲ 115%
Net profit · FY 2024
₹3.27 Lakh margin 1.2%
EBITDA · FY 2024
₹5.82 Lakh margin 2.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 115%
3 years · compounded
▲ 80%
EBITDA CAGR growth
1 year
▲ 151%
3 years · compounded
▲ 84%
Revenue has grown at a compounded annual rate (CAGR) of 80% over three years, including 115% growth in the latest year. EBITDA rose 151% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.82 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.27 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ingram Biosciences Private Limited, buy the company report.
Board of directors of Ingram Biosciences Private Limited
Ingram Biosciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Auditor
Ingram Biosciences Private Limited is audited by NEHA TEOTIA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NEHA TEOTIA & ASSOCIATES | FY 2023 | 019075C |
Shareholding
The shareholding of Ingram Biosciences Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Ingram Biosciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ingram Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ingram Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ingram Biosciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCI2541C1Z1 | Delhi | Active | 26 May 2019 |
To see the full GST registrations and return filing status of Ingram Biosciences Private Limited, buy the company report.
Recent activity
Ingram Biosciences Private Limited has 8 board changes on record since 2019: 5 appointments and 3 cessations. The latest: Subhash Chandra Pathak ceased to be Director on 06 Apr 2022.
AGM
Ingram Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ingram Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Ceased
Subhash Chandra Pathak ceased to be Director.
Appointed
Sakshi was appointed as Director.
Appointed
Jeet Mala was appointed as Director.
Ceased
Kul Bhushan Sharma ceased to be Director.
Appointed
Subhash Chandra Pathak was appointed as Director.
Ceased
Vineet Khanna ceased to be Director.
Appointed
Kul Bhushan Sharma was appointed as Director.
Appointed
Vineet Khanna was appointed as Director.
Incorporation
24 Apr 2019
Ingram Biosciences Private Limited was registered on 24 Apr 2019 with Roc Uttar Pradesh Ii & aged 7 years 6 months as per MCA records.
Frequently asked questions
Ingram Biosciences is an active private limited company based in Noida, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 April 2019 (7+ years old) and is registered under CIN U24230UP2019PTC116200.
The latest financial statements of Ingram Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Ingram Biosciences is 07AAFCI2541C1Z1, registered in Delhi.
The CIN (Corporate Identification Number) of Ingram Biosciences is U24230UP2019PTC116200. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ingram Biosciences was incorporated on 24 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Subhash Chandra Pathak ceased to be Director on 06 Apr 2022. Sakshi was appointed as Director on 05 Jan 2022. Jeet Mala was appointed as Director on 31 Jul 2019. Ingram Biosciences has 8 board changes on record in total.
Yes, Ingram Biosciences is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0033795).
Ingram Biosciences can be reached through the website ingrambiosciences.com. Its registered office is in Noida, Uttar Pradesh, India.
The registered office of Ingram Biosciences is at 1203 2nd Floor Ats Greens – 2 Plot No A – 58 Sector 50, Noida, Uttar Pradesh, India – 201301.